atomic occlusion rates after
EVLA were signiﬁcantly better than those after MOCA
(91% vs 77%; P ¼ .020). Both EVLA and MOCA were highly
efﬁcacious at 2 years and both had signiﬁcantly
improved disease severity, symptoms, and QoL. In
another RCT by Tawﬁk et al,182 100 patients had been
